Clinical Trial Update: ACRYSOF® ReSTOR® Aspheric +3.0 D Add Power Intraocular Lens (IOL) [Phase 4]

View source ↗

Summary

Phase 4 trial update for the ACRYSOF ReSTOR Aspheric +3.0 D Add Power Intraocular Lens in cataract patients; results were posted following completion of the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• ACRYSOF ReSTOR Aspheric +3.0 D Add Power Intraocular Lens

Snippet

Sponsor: Alcon Research | Conditions: Cataract | Phase 4 | Status: COMPLETED | Results posted: 2010-03-11